Barinthus Biotherapeutics PLC
NASDAQ:BRNS
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Barinthus Biotherapeutics PLC
NASDAQ:BRNS
|
UK |
|
C
|
CoStar Group Inc
XMUN:RLG
|
US |
|
Dentsu Group Inc
F:DEN0
|
JP |
|
Biomerieux SA
F:EYWN
|
FR |
|
H
|
Halliburton Co
SWB:HAL
|
US |
|
Omni Health Inc
OTC:OMHE
|
US |
|
F
|
Fuyao Glass Industry Group Co Ltd
F:4FG
|
CN |
|
E
|
Eisen und Huettenwerke AG
F:EIS
|
DE |
|
S
|
Skymoons Technology Inc
KOSDAQ:033790
|
KR |
|
Prosus NV
OTC:PROSF
|
NL |
Intrinsic Value
The intrinsic value for
Barinthus Biotherapeutics PLC (BRNS) under the Base Case is hidden
USD.
Compared with the current market price of 0.7194 USD, the stock appears hidden
.
Do our valuations actually work? See backtest results .
BRNS looks overvalued. Yet it might still be cheap by its own standards. Some stocks live permanently above intrinsic value; Historical Valuation reveals whether BRNS usually does or if today's premium is unusual.
See where today’s valuation sits in BRNS’s own history and what typically happened over the next 12 months after similar periods.
Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.
Let our AI break down the key assumptions behind the intrinsic value calculation for Barinthus Biotherapeutics PLC.
The intrinsic value for
Barinthus Biotherapeutics PLC (BRNS) under the Base Case is hidden USD.
Compared with the current market price of 0.7194 USD, the stock appears hidden.